Get the Stockscreener App
16.00
6.78%
1.0161
Vtv Therapeutics Inc stock is traded at $16.00, with a volume of 1,107.
It is up +6.78% in the last 24 hours and down -6.05% over the past month.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
See More
Previous Close:
$14.98
Open:
$14.55
24h Volume:
1,107
Relative Volume:
0.21
Market Cap:
$41.88M
Revenue:
$5.02M
Net Income/Loss:
$-18.31M
P/E Ratio:
-3.532
EPS:
-4.53
Net Cash Flow:
$-23.40M
1W Performance:
+3.63%
1M Performance:
-6.05%
6M Performance:
-20.79%
1Y Performance:
-4.05%
1-Day Range:
$14.55
$16.00
1-Week Range:
$14.55
$16.00
52-Week Range:
$12.62
$26.99
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Name
Vtv Therapeutics Inc
Sector
Industry
Phone
336-841-0300
Address
3980 PREMIER DR, HIGH POINT, NC
Compare VTVT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
16.00 | 40.62M | 5.02M | -18.31M | -23.40M | -4.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-30-19 | Initiated | H.C. Wainwright | Buy |
| Apr-10-18 | Downgrade | Stifel | Buy → Hold |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-08-18 | Initiated | Northland Capital | Outperform |
| Sep-26-16 | Initiated | H.C. Wainwright | Buy |
| Sep-04-15 | Initiated | Canaccord Genuity | Buy |
| Aug-24-15 | Initiated | Piper Jaffray | Overweight |
| Aug-24-15 | Initiated | Stifel | Buy |
View All
Vtv Therapeutics Inc Stock (VTVT) Latest News
vTv Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Macro Moves & Real-Time Volume Triggers - Newser
Smart tools for monitoring vTv Therapeutics Inc.’s price actionWeekly Investment Report & Weekly High Conviction Ideas - Newser
What machine learning models say about vTv Therapeutics Inc.2025 Market Sentiment & Smart Investment Allocation Tips - Newser
How to build a custom watchlist for vTv Therapeutics Inc.July 2025 PreEarnings & Long-Term Investment Growth Plans - Newser
Chart based analysis of vTv Therapeutics Inc. trendsEntry Point & Low Risk Entry Point Tips - Newser
What to do if you’re stuck in vTv Therapeutics Inc.Trade Analysis Report & Daily Risk Controlled Trade Plans - Newser
How vTv Therapeutics Inc. stock performs during market volatilityJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Can trapped investors hope for a rebound in vTv Therapeutics Inc.July 2025 Pullbacks & Proven Capital Preservation Tips - Newser
Should you hold or exit vTv Therapeutics Inc. now2025 Short Interest & Stepwise Trade Signal Guides - Newser
vTv Therapeutics Inc. stock daily chart insightsMarket Movement Recap & Long Hold Capital Preservation Plans - Newser
Custom strategy builders for tracking vTv Therapeutics Inc.Portfolio Return Summary & Capital Protection Trade Alerts - Newser
How Resilient Is vTv Therapeutics Inc. Stock During Economic DownturnsJuly 2025 Volume & Fast Gaining Stock Reports - Newser
What earnings revisions data tells us about vTv Therapeutics Inc.July 2025 PreEarnings & Long-Term Investment Growth Plans - Newser
Is vTv Therapeutics Inc. trending in predictive chart modelsJuly 2025 Spike Watch & Daily Oversold Bounce Ideas - Newser
vTv Therapeutics Inc. Stock Support and Resistance Levels You Should KnowWeekly Trend Report & Low Risk High Win Rate Stock Picks - Newser
Does vTv Therapeutics Inc. fit your quant trading modelQuarterly Trade Report & Precise Swing Trade Alerts - Newser
vTv Therapeutics Inc. stock retracement – recovery analysisDay Trade & Low Risk Investment Opportunities - Newser
HC Wainwright Forecasts Lower Earnings for vTv Therapeutics - Defense World
Should I buy vTv Therapeutics Inc. stock before earningsWeekly Gains Summary & Community Verified Swing Trade Signals - Newser
Will Volume Confirm Reversal in vTv Therapeutics Inc.2025 Breakouts & Breakdowns & Free Technical Pattern Based Buy Signals - sundaytimes.kr
Why vTv Therapeutics Inc. stock attracts strong analyst attentionMarket Growth Review & AI Driven Stock Reports - Newser
vTv Therapeutics (NASDAQ:VTVT) Earns Buy Rating from HC Wainwright - Defense World
vTv Therapeutics Inc. Hits Oversold Level on RSI IndicatorJuly 2025 Summary & Smart Swing Trading Techniques - newsyoung.net
Buy Signal for vTv Therapeutics Inc. Stock Key Technical Indicators to WatchRate Cut & Risk Adjusted Buy/Sell Alerts - Newser
VTv Therapeutics Q2 Financial Results: $6M LossNews and Statistics - IndexBox
Short Interest Drops in vTv Therapeutics Inc. After RallyJuly 2025 Pullbacks & Capital Protection Trade Alerts - beatles.ru
VTv Therapeutics: Q2 Earnings Snapshot - Huron Daily Tribune
Optimistic Buy Rating for vTv Therapeutics Driven by Clinical Progress and Strategic Advancements - TipRanks
vTv Therapeutics Reports Q2 2025 Financials, Advances Cadisegliatin Trials, and Appoints New CFO - AInvest
How to monitor vTv Therapeutics Inc. with trend dashboardsFree Alpha Driven Watchlist With Alerts - Newser
What’s next for vTv Therapeutics Inc. stock priceEquity Signal Recap With Long-Term Summary - Newser
Vtv Therapeutics Inc Stock (VTVT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):